Expand your knowledge through our webinars!

The ins and outs of nucleocytoplasmic trafficking in ALS/FTD

 

In this webinar, Dr. Rita Sattler, Barrow Neurological Institute, discusses the latest insights into the mechanisms of dysfunctional nuclear-cytoplasmic trafficking of RNA binding proteins and how they might contribute to neurodegeneration in ALS/FTD.

The webinar was hosted by Nature Research and sponsored by Atlas Antibodies. The recording is the property of Atlas Antibodies.

 

Glioma Biology and Molecular Markers

 

Date: October 21, 2021
Speaker: Dr. Carolyn Marks, Research Scientist, Atlas Antibodies

Gliomas are heterogeneous tumors derived from glial cells and remain the deadliest form of brain cancer. This webinar features the history of glioma classification, the evolution of the molecular-based classification, and the emergence of an integrated diagnosis. Specific molecular markers are highlighted that revolutionized glioma biology and the clinical ramifications of misclassification are described. A summary of the current genetic, proteomic, and cellular biomarkers of glioma is presented. The current approaches and challenges in glioma diagnosis, therapy, and prognosis are described. Finally, existing, and upcoming proteomic resources are offered to aid in overcoming the major hurdles in glioma diagnostics and treatment today.

The webinar was hosted by American Association for Cancer Research (AACR) and sponsored by Atlas Antibodies. The recording is the property of Atlas Antibodies.

 

The Brain Atlas: A road map through the complex protein signature of the brain

 

During this webinar the speakers focused on:

  • Explaining the data generation and the features of the Brain Atlas
  • Discussing the process for the identification and characterization of both brains- and regional-specific proteins and how they overlap
  • Understanding the different strategies for profiling proteins in the mammalian brain

This webinar was hosted by Science and sponsored by Atlas Antibodies. The recording is the property of Atlas Antibodies.

 

Integration of transcriptomics and antibody-based proteomicsfor cell type-specific localization
of SARS-CoV-2 related proteins

 

In this webinar, Dr. Cecilia Lindskog presents the cell type-specific expression of ACE2 across more than 150 different cell types corresponding to all major human tissues and organs based on stringent immunohistochemical analysis. The results are compared with different datasets both on the mRNA and protein level. She also discusses the importance of integration of transcriptomics and antibody-based proteomics in studies on SARS-CoV-2 host cell entry, in order to understand the biology of the disease and to aid in the development of effective treatments to the viral infection.

The webinar was hosted by Atlas Antibodies. The recording is the property of Atlas Antibodies.